Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alignment Healthcare (ALHC) Net Income towards Common Stockholders (2020 - 2025)

Historic Net Income towards Common Stockholders for Alignment Healthcare (ALHC) over the last 6 years, with Q3 2025 value amounting to $3.7 million.

  • Alignment Healthcare's Net Income towards Common Stockholders rose 11410.95% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$21.0 million, marking a year-over-year increase of 8541.58%. This contributed to the annual value of -$128.1 million for FY2024, which is 1356.66% up from last year.
  • Latest data reveals that Alignment Healthcare reported Net Income towards Common Stockholders of $3.7 million as of Q3 2025, which was up 11410.95% from $15.7 million recorded in Q2 2025.
  • Alignment Healthcare's Net Income towards Common Stockholders' 5-year high stood at $15.7 million during Q2 2025, with a 5-year trough of -$57.0 million in Q4 2022.
  • Its 5-year average for Net Income towards Common Stockholders is -$32.2 million, with a median of -$37.4 million in 2023.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first tumbled by 63511.06% in 2021, then surged by 16521.27% in 2025.
  • Quarter analysis of 5 years shows Alignment Healthcare's Net Income towards Common Stockholders stood at -$47.8 million in 2021, then dropped by 19.15% to -$57.0 million in 2022, then rose by 17.13% to -$47.2 million in 2023, then skyrocketed by 34.23% to -$31.1 million in 2024, then skyrocketed by 112.0% to $3.7 million in 2025.
  • Its last three reported values are $3.7 million in Q3 2025, $15.7 million for Q2 2025, and -$9.4 million during Q1 2025.